Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
RSC Medicinal Chemistry
|
December 15, 2025
Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitors
Jeffrey M Axten, Xiao Ding, Luigi Piero Stasi, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2004
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies
Dai-Shi Su, M Kristine Markowitz, Kathy L Murphy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 31, 2004
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
J Fred Hess, Richard W Ransom, Zhizhen Zeng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2023
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines
Sun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, et al.
Science Translational Medicine
|
May 20, 2021
ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity
Michael Shum, Chitra A Shintre, Thorsten Althoff, et al.
Cell Reports. Medicine
|
October 11, 2022
Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial
Mingqian He, Jingya Wang, Qian Liang, et al.
Journal of Medicinal Chemistry
|
November 4, 2009
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses
Dai-Shi Su, John J Lim, Elizabeth Tinney, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors
Dai-Shi Su, Junya Qu, Mark Schulz, et al.
European Journal of Pharmacology
|
September 15, 2004
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist
Richard W Ransom, Charles M Harrell, Duane R Reiss, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants
Dai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
RSC Medicinal Chemistry
|
December 15, 2025
Discovery and optimization of pyrrolopyrimidines as highly potent, selective and brain-penetrant LRRK2 inhibitors
Jeffrey M Axten, Xiao Ding, Luigi Piero Stasi, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 18, 2004
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies
Dai-Shi Su, M Kristine Markowitz, Kathy L Murphy, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 31, 2004
Generation and characterization of a human bradykinin receptor B1 transgenic rat as a pharmacodynamic model
J Fred Hess, Richard W Ransom, Zhizhen Zeng, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 19, 2023
Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines
Sun Hyun Bae, Seok-Joo Chun, Joo-Hyun Chung, et al.
Science Translational Medicine
|
May 20, 2021
ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity
Michael Shum, Chitra A Shintre, Thorsten Althoff, et al.
Cell Reports. Medicine
|
October 11, 2022
Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial
Mingqian He, Jingya Wang, Qian Liang, et al.
Journal of Medicinal Chemistry
|
November 4, 2009
Biaryl ethers as novel non-nucleoside reverse transcriptase inhibitors with improved potency against key mutant viruses
Dai-Shi Su, John J Lim, Elizabeth Tinney, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of Isoxazole Amides as Potent and Selective SMYD3 Inhibitors
Dai-Shi Su, Junya Qu, Mark Schulz, et al.
European Journal of Pharmacology
|
September 15, 2004
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist
Richard W Ransom, Charles M Harrell, Duane R Reiss, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 28, 2009
Substituted tetrahydroquinolines as potent allosteric inhibitors of reverse transcriptase and its key mutants
Dai-Shi Su, John J Lim, Elizabeth Tinney, et al.
Page
of 15